The carboxyl-terminal region of erythroid-specific 5-aminolevulinate synthase acts as an intrinsic modifier for its catalytic activity and protein stability

Experimental Hematology

Volumn 40, Issue 6, 2012, Pages

  Kadirvel, Senkottuvelan ^a   Furuyama, Kazumichi ^a   Harigae, Hideo ^a   Kaneko, Kiriko ^a   Tamai, Yoshiko ^b   Ishida, Yoji ^c   Shibahara, Shigeki ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HIROSAKI UNIVERSITY HOSPITAL   (Japan)

^c IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; PORPHYRIN; PYRIDOXINE;

ADOLESCENT; ADULT; ALAS2 GENE; ARTICLE; BONE MARROW EXAMINATION; CARBOXY TERMINAL SEQUENCE; CASE REPORT; GENE; GENE MAPPING; HEMOGLOBIN BLOOD LEVEL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTRON; MALE; MISSENSE MUTATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; TREATMENT RESPONSE; X LINKED SIDEROBLASTIC ANEMIA;

EUKARYOTA; PROKARYOTA;

EID: 84860840893     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.01.013     Document Type: Article

References (47)

1. Anderson K.E., Sassa S., Bishop D.F., Desnick R.J. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. The Metabolic & Molecular Bases of Inherited Disease 2001, 2991-3062. McGraw-Hill Medical Publishing Division, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
2. Hayashi N., Yoda B., Kikuchi G. Difference in molecular sizes of delta-aminolevulinate synthetases in the soluble and mitochondrial fractions of rat liver. J Biochem 1970, 67:859-861.
3. Bishop D.F., Henderson A.S., Astrin K.H. Human delta-aminolevulinate synthase: assignment of the housekeeping gene to 3p21 and the erythroid-specific gene to the X chromosome. Genomics 1990, 7:207-214.
4. Lathrop J.T., Timko M.P. Regulation by heme of mitochondrial protein transport through a conserved amino acid motif. Science 1993, 259:522-525.
5. Munakata H., Sun J.Y., Yoshida K., et al. Role of the heme regulatory motif in the heme-mediated inhibition of mitochondrial import of 5-aminolevulinate synthase. J Biochem 2004, 136:233-238.
6. Dailey T.A., Woodruff J.H., Dailey H.A. Examination of mitochondrial protein targeting of haem synthetic enzymes: in vivo identification of three functional haem-responsive motifs in 5-aminolaevulinate synthase. Biochem J 2005, 386:381-386.
7. Munakata H., Yamagami T., Nagai T., Yamamoto M., Hayashi N. Purification and structure of rat erythroid-specific delta-aminolevulinate synthase. J Biochem 1993, 114:103-111.
8. Cox T.C., Bawden M.J., Abraham N.G., et al. Erythroid 5-aminolevulinate synthase is located on the X chromosome. Am J Hum Genet 1990, 46:107-111.
9. Cox T.C., Bottomley S.S., Wiley J.S., Bawden M.J., Matthews C.S., May B.K. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase. N Engl J Med 1994, 330:675-679.
10. Cotter P.D., Baumann M., Bishop D.F. Enzymatic defect in " X-linked" sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency. Proc Natl Acad Sci U S A 1992, 89:4028-4032.
11. Whatley S.D., Ducamp S., Gouya L., et al. C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet 2008, 83:408-414.
12. Bottomley S.S. Sideroblastic anemias. Wintrobe's Clinical Hematology 2009, 835-856. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia/London. 12th ed. J.P. Greer, J. Foerster, G.M. Rogers (Eds.).
13. Harigae H., Furuyama K. Hereditary sideroblastic anemia: pathophysiology and gene mutations. Int J Hematol 2010, 92:425-431.
14. Ducamp S., Kannengiesser C., Touati M., et al. Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations. Hum Mutat 2011, 32:590-597.
15. Harigae H., Furuyama K., Kimura A., et al. A novel mutation of the erythroid-specific delta-aminolaevulinate synthase gene in a patient with X-linked sideroblastic anaemia. Br J Haematol 1999, 106:175-177.
16. Cazzola M., May A., Bergamaschi G., Cerani P., Ferrillo S., Bishop D.F. Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation. Blood 2002, 100:4236-4238.
17. Astner I., Schulze J.O., van den Heuvel J., Jahn D., Schubert W.D., Heinz D.W. Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans. EMBO J 2005, 24:3166-3177.
18. To-Figueras J., Ducamp S., Clayton J., et al. ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria. Blood 2011, 118:1443-1451.
19. Sambrook J., Russell D.W. Molecular Cloning: A Laboratory Manual 2001, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 3rd ed.
20. Furuyama K., Fujita H., Nagai T., et al. Pyridoxine refractory X-linked sideroblastic anemia caused by a point mutation in the erythroid 5-aminolevulinate synthase gene. Blood 1997, 90:822-830.
21. Furuyama K., Harigae H., Heller T., et al. Arg452 substitution of the erythroid-specific 5-aminolaevulinate synthase, a hot spot mutation in X-linked sideroblastic anaemia, does not itself affect enzyme activity. Eur J Haematol 2006, 76:33-41.
22. Furuyama K., Sassa S. Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia. J Clin Invest 2000, 105:757-764.
23. Kaneko K., Furuyama K., Aburatani H., Shibahara S. Hypoxia induces erythroid-specific 5-aminolevulinate synthase expression in human erythroid cells through transforming growth factor-beta signaling. FEBS J 2009, 276:1370-1382.
24. Guernsey D.L., Jiang H., Campagna D.R., et al. Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia. Nat Genet 2009, 41:651-653.
25. Ye H., Jeong S.Y., Ghosh M.C., et al. Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts. J Clin Invest 2010, 120:1749-1761.
26. Allikmets R., Raskind W.H., Hutchinson A., Schueck N.D., Dean M., Koeller D.M. Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet 1999, 8:743-749.
27. Bykhovskaya Y., Casas K., Mengesha E., Inbal A., Fischel-Ghodsian N. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 2004, 74:1303-1308.
28. Ricketts C.J., Minton J.A., Samuel J., et al. Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families. Acta Paediatr 2006, 95:99-104.
29. Rotig A., Colonna M., Bonnefont J.P., et al. Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet 1989, 1:902-903.
30. Bergmann A.K., Campagna D.R., McLoughlin E.M., et al. Systematic molecular genetic analysis of congenital sideroblastic anemia: evidence for genetic heterogeneity and identification of novel mutations. Pediatr Blood Cancer 2010, 54:273-278.
31. Cotter P.D., Rucknagel D.L., Bishop D.F. X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley. Blood 1994, 84:3915-3924.
32. Cotter P.D., May A., Fitzsimons E.J., et al. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts. J Clin Invest 1995, 96:2090-2096.
33. Prades E., Chambon C., Dailey T.A., Dailey H.A., Briere J., Grandchamp B. A new mutation of the ALAS2 gene in a large family with X-linked sideroblastic anemia. Hum Genet 1995, 95:424-428.
34. Furuyama K., Uno R., Urabe A., et al. R411C mutation of the ALAS2 gene encodes a pyridoxine-responsive enzyme with low activity. Br J Haematol 1998, 103:839-841.
35. Harigae H., Furuyama K., Kudo K., et al. A novel mutation of the erythroid-specific delta-Aminolevulinate synthase gene in a patient with non-inherited pyridoxine-responsive sideroblastic anemia. Am J Hematol 1999, 62:112-114.
36. Furuyama K., Harigae H., Kinoshita C., et al. Late-onset X-linked sideroblastic anemia following hemodialysis. Blood 2003, 101:4623-4624.
37. Ferreira G.C., Neame P.J., Dailey H.A. Heme biosynthesis in mammalian systems: evidence of a Schiff base linkage between the pyridoxal 5'-phosphate cofactor and a lysine residue in 5-aminolevulinate synthase. Protein Sci 1993, 2:1959-1965.
38. Gong J., Ferreira G.C. Aminolevulinate synthase: functionally important residues at a glycine loop, a putative pyridoxal phosphate cofactor-binding site. Biochemistry 1995, 34:1678-1685.
39. Tan D., Ferreira G.C. Active site of 5-aminolevulinate synthase resides at the subunit interface. Evidence from in vivo heterodimer formation. Biochemistry 1996, 35:8934-8941.
40. Gong J., Hunter G.A., Ferreira G.C. Aspartate-279 in aminolevulinate synthase affects enzyme catalysis through enhancing the function of the pyridoxal 5'-phosphate cofactor. Biochemistry 1998, 37:3509-3517.
41. Tan D., Barber M.J., Ferreira G.C. The role of tyrosine 121 in cofactor binding of 5-aminolevulinate synthase. Protein Sci 1998, 7:1208-1213.
42. Tan D., Harrison T., Hunter G.A., Ferreira G.C. Role of arginine 439 in substrate binding of 5-aminolevulinate synthase. Biochemistry 1998, 37:1478-1484.
43. Turbeville T.D., Zhang J., Hunter G.A., Ferreira G.C. Histidine 282 in 5-aminolevulinate synthase affects substrate binding and catalysis. Biochemistry 2007, 46:5972-5981.
44. Lendrihas T., Zhang J., Hunter G.A., Ferreira G.C. Arg-85 and Thr-430 in murine 5-aminolevulinate synthase coordinate acyl-CoA-binding and contribute to substrate specificity. Protein Sci 2009, 18:1847-1859.
45. Lendrihas T., Hunter G.A., Ferreira G.C. Serine 254 enhances an induced fit mechanism in murine 5-aminolevulinate synthase. J Biol Chem 2010, 285:3351-3359.
46. Lendrihas T., Hunter G.A., Ferreira G.C. Targeting the active site gate to yield hyperactive variants of 5-aminolevulinate synthase. J Biol Chem 2010, 285:13704-13711.
47. Zhang J., Ferreira G.C. Transient state kinetic investigation of 5-aminolevulinate synthase reaction mechanism. J Biol Chem 2002, 277:44660-44669.